3-(phenylamino)alanine has been researched along with 2,3-diaminopropionic acid in 1 studies
| Studies (3-(phenylamino)alanine) | Trials (3-(phenylamino)alanine) | Recent Studies (post-2010) (3-(phenylamino)alanine) | Studies (2,3-diaminopropionic acid) | Trials (2,3-diaminopropionic acid) | Recent Studies (post-2010) (2,3-diaminopropionic acid) |
|---|---|---|---|---|---|
| 25 | 0 | 6 | 83 | 0 | 38 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Belongia, EA; Gleich, GJ; Lin, F; Lundy, SK; Mayeno, AN | 1 |
1 other study(ies) available for 3-(phenylamino)alanine and 2,3-diaminopropionic acid
| Article | Year |
|---|---|
3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
Topics: Alanine; beta-Alanine; Brassica; Chromatography, High Pressure Liquid; Drug Contamination; Eosinophilia-Myalgia Syndrome; Fatty Acids, Monounsaturated; Plant Oils; Rapeseed Oil; Spain; Tryptophan; United States | 1992 |